|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2007;83:1264
© 2007 The Society of Thoracic Surgeons
St. Lukes Health Network, 701 Ostrum St, Suite 201, Bethlehem, PA 18015
(Email: burfeiw@slhn.org).
| The first 20% of the full text of this article appears below. |
Decision-making surrounding the care of patients with locally advanced esophageal cancer remains complex. This is primarily due to the fact that the available data supporting surgery alone versus multimodal therapy are conflicting. What seems clear is that there is not an overwhelming survival advantage to either therapy and that there are few long-term survivors with this disease. In this setting it seems particularly important to consider health-related quality of life (HRQOL) when performing medical decision-making.
Graham and colleagues [1] are to be congratulated on bringing two powerful medical decision-making tools (ie, meta-analysis and decision analysis) to bear on the optimal therapy for locally
Related Article
Ann. Thorac. Surg. 2007 83: 1257-1264.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |